封面
市场调查报告书
商品编码
1618176

耳鼻喉科设备市场机会、成长动力、产业趋势分析及 2024 年至 2032 年预测

ENT Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球耳鼻喉科设备市场价值 208 亿美元,预计在整个预测期内复合年增长率为 6.3%。这种增长可归因于多种因素,包括外科和诊断程序数量的增加、耳鼻喉疾病盛行率的显着增加以及旨在提高对这些疾病认识的积极政府措施。市场扩张的关键驱动力之一是助听器和人工耳蜗的日益认可和采用。随着人口老化,听力损失的发生率激增,导致对这些辅助设备的需求增加。

技术进步,例如配备蓝牙连接和降噪功能的智慧助听器的开发,进一步丰富了用户体验并刺激了该行业的成长。从产品类型来看,助听器细分市场占据了很大的市场份额,到2023 年将占总份额的37.2%。寻求治疗。此外,旨在提高助听器普及率的政府政策和倡议,特别是在发展中地区,在促进市场成长方面发挥关键作用。就最终用户而言,耳鼻喉设备市场分为医院、门诊手术中心、耳鼻喉诊所和家庭护理。

2023 年,医院领域以 36% 的份额主导市场,反映出耳鼻喉科诊断和手术设备在这些环境中的使用率不断上升。最近的技术进步产生了精确有效的诊断工具,例如高清内视镜和先进的成像系统。这些创新提高了诊断的准确性和治疗计划的有效性。耳鼻喉科疾病(包括慢性鼻窦炎、睡眠呼吸中止症和听力损失)的发生率不断上升,进一步推动了这些先进诊断和手术解决方案的需求。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 208亿美元
预测值 360 亿美元
复合年增长率 6.3%

在北美,耳鼻喉科设备市场将于 2023 年达到 81 亿美元,预计在分析期间复合年增长率为 5.2%。该地区疾病患病率高、医疗基础设施健全以及对技术创新的承诺推动了对耳鼻喉科设备的强劲需求。此外,人口老化和耳鼻喉科健康意识的提高也是促成因素。新产品的不断批准和先进技术的引进也有望对市场成长产生积极影响。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球耳鼻喉科疾病盛行率不断上升
      • 老年人口增加
      • 耳鼻喉科设备的技术进步
      • 对微创耳鼻喉手术的需求不断增长
    • 产业陷阱与挑战
      • 程序和仪器成本高
      • 全球各地的社会耻辱
  • 成长潜力分析
  • 报销场景
    • 我们
    • 欧洲
  • 技术景观
  • 监管环境
    • 我们
    • 欧洲
  • 未来市场趋势
  • 价值链分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品类型,2021 - 2032 年

  • 主要趋势
  • 耳鼻喉 (ENT) 诊断设备
    • 硬内视镜
      • 鼻镜
      • 喉镜
      • 耳科内视镜
    • 软式内视镜
    • 机器人辅助内视镜
    • 听力筛检设备
  • 耳鼻喉 (ENT) 外科设备
    • 射频手机
    • 动力手术器械
    • 耳科钻头
    • 耳鼻喉科手持器械
    • 鼓膜造口管
    • 鼻窦扩张装置
    • 鼻腔填塞装置
  • 助听器
    • 耳背式 (BTE)
    • 完全在根管内/隐形在根管内 (CIC/IIC)
    • 运河内 [运河内 (ITC)]
    • 入耳式 (ITE)
    • 耳内接收器/耳道接收器 (RITE/RIC)
  • 听力植入物
    • 听觉脑干植入物
    • 人工耳蜗
    • 中耳植入物
    • 骨锚式听力系统
  • 发声义肢装置
  • 鼻夹板
    • 内鼻夹板
    • 鼻外夹板

第 6 章:市场估计与预测:依最终用途,2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 耳鼻喉科诊所
  • 居家护理

第 7 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 土耳其

第 8 章:公司简介

  • Atos Medical
  • Boston Scientific Corporation
  • Cochlear
  • DeSoutter Medical
  • Johnson & Johnson
  • Lumenis
  • Medtronic
  • Meril Life Sciences
  • Narang Medical
  • Nouvag
  • Olympus Corporation
  • Smith & Nephew
  • Sonova Group
  • Stryker Corporation
  • Vega Medical
  • Welch Allyn
  • WestCMR
  • Zimmer Biomet
简介目录
Product Code: 496

The Global ENT Devices Market was worth USD 20.8 billion in 2023 and is projected to experience 6.3% CAGR throughout the forecast period. This growth can be attributed to several factors, including the rising number of surgical and diagnostic procedures, a significant increase in the prevalence of ENT disorders, and proactive government initiatives aimed at raising awareness about these conditions. One of the key drivers of market expansion is the growing recognition and uptake of hearing aids and cochlear implants. As populations age, the incidence of hearing loss has surged, resulting in heightened demand for these assistive devices.

Technological advancements, such as the development of smart hearing aids equipped with Bluetooth connection and noise-cancellation features, have further enriched the user experience and stimulated growth in this sector. Based on product type, the hearing aids segment represented a significant portion of the market, accounting for 37.2% of the total share in 2023. The increasing awareness of hearing loss's impact on overall quality of life is motivating more individuals to pursue treatment. Furthermore, government policies and initiatives designed to enhance access to hearing aids, particularly in developing regions, are playing a pivotal role in fostering market growth. In terms of end users, the ENT devices market is segmented into hospitals, ambulatory surgical centers, ENT clinics, and home care.

The hospital segment dominated the market with a share of 36% in 2023, reflecting the rising utilization of ENT diagnostic and surgical devices in these settings. Recent technological advancements have yielded precise and effective diagnostic tools, such as high-definition endoscopes and advanced imaging systems. These innovations have improved the accuracy of diagnoses and the efficacy of treatment planning. The growing incidence of ENT disorders, including chronic sinusitis, sleep apnea, and hearing loss, is further driving the demand for these advanced diagnostics and surgical solutions.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$20.8 Billion
Forecast Value$36 Billion
CAGR6.3%

In North America, the ENT devices market reached USD 8.1 billion in 2023 and is anticipated to grow at a CAGR of 5.2% over the analysis period. The strong demand for ENT devices in this region is fueled by a high prevalence of disorders, a robust healthcare infrastructure, and a commitment to technological innovation. Additionally, an aging population and heightened awareness regarding ENT health are contributing factors. The continuous approval of new products and the introduction of advanced technologies are also expected to positively influence market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of ENT disorders globally
      • 3.2.1.2 Increasing geriatric population
      • 3.2.1.3 Technological advancements in the ENT devices
      • 3.2.1.4 Rising demand for minimally invasive ENT procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedure and instruments cost
      • 3.2.2.2 Social stigma across the globe
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technological landscape
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Future market trends
  • 3.8 Value-chain analysis
  • 3.9 Gap analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostic ear, nose, and throat (ENT) devices
    • 5.2.1 Rigid endoscopes
      • 5.2.1.1 Rhinoscopes
      • 5.2.1.2 Laryngoscopes
      • 5.2.1.3 Otological endoscopes
    • 5.2.2 Flexible endoscopes
    • 5.2.3 Robot assisted endoscopes
    • 5.2.4 Hearing screening devices
  • 5.3 Surgical ear, nose, and throat (ENT) devices
    • 5.3.1 Radiofrequency handpieces
    • 5.3.2 Powered surgical instruments
    • 5.3.3 Otological drill burrs
    • 5.3.4 ENT hand instruments
    • 5.3.5 Tympanostomy tubes
    • 5.3.6 Sinus dilation devices
    • 5.3.7 Nasal packing devices
  • 5.4 Hearing aids
    • 5.4.1 Behind-the-ear (BTE)
    • 5.4.2 Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
    • 5.4.3 In-the-canal [In-the-canal (ITC)]
    • 5.4.4 In-the-ear (ITE)
    • 5.4.5 Receiver in the ear/Receiver in canal (RITE/RIC)
  • 5.5 Hearing implants
    • 5.5.1 Auditory brainstem implants
    • 5.5.2 Cochlear implants
    • 5.5.3 Middle ear implants
    • 5.5.4 Bone anchored hearing systems
  • 5.6 Voice prosthesis devices
  • 5.7 Nasal splints
    • 5.7.1 Internal nasal splints
    • 5.7.2 External nasal splints

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Ambulatory surgical centers
  • 6.4 ENT clinics
  • 6.5 Homecare

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Turkey

Chapter 8 Company Profiles

  • 8.1 Atos Medical
  • 8.2 Boston Scientific Corporation
  • 8.3 Cochlear
  • 8.4 DeSoutter Medical
  • 8.5 Johnson & Johnson
  • 8.6 Lumenis
  • 8.7 Medtronic
  • 8.8 Meril Life Sciences
  • 8.9 Narang Medical
  • 8.10 Nouvag
  • 8.11 Olympus Corporation
  • 8.12 Smith & Nephew
  • 8.13 Sonova Group
  • 8.14 Stryker Corporation
  • 8.15 Vega Medical
  • 8.16 Welch Allyn
  • 8.17 WestCMR
  • 8.18 Zimmer Biomet